TNNI3 and hydrops fetalis: In another post hoc analysis from the TOPCAT trial, higher levels of hs-cTnI were independently associated with an increased risk of CV mortality or HF hospitalization (HR, 1.42; 95% CI, 1.20–1.69; p value < 0.001 per doubling of hs-cTnI).